Log in to save to my catalogue

Sensitivity of anti-SARS-CoV-2 serological assays in a high-prevalence setting

Sensitivity of anti-SARS-CoV-2 serological assays in a high-prevalence setting

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7856849

Sensitivity of anti-SARS-CoV-2 serological assays in a high-prevalence setting

About this item

Full title

Sensitivity of anti-SARS-CoV-2 serological assays in a high-prevalence setting

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

European journal of clinical microbiology & infectious diseases, 2021-05, Vol.40 (5), p.1063-1071

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Evaluation and power of seroprevalence studies depend on the performed serological assays. The aim of this study was to assess four commercial serological tests from EUROIMMUN, DiaSorin, Abbott, and Roche as well as an in-house immunofluorescence and neutralization test for their capability to identify SARS-CoV-2 seropositive individuals in a high-...

Alternative Titles

Full title

Sensitivity of anti-SARS-CoV-2 serological assays in a high-prevalence setting

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7856849

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7856849

Other Identifiers

ISSN

0934-9723

E-ISSN

1435-4373

DOI

10.1007/s10096-021-04169-7

How to access this item